Drug Profile
NTC 121
Alternative Names: NTC-121Latest Information Update: 08 Oct 2002
Price :
$50
*
At a glance
- Originator Neurotech SA
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glioma
Most Recent Events
- 23 Aug 2002 Discontinued - Phase-II for Glioma in France (unspecified route)
- 19 Dec 2000 NTC 121 is available for licensing (http://www.neurotech.fr)
- 15 May 2000 Phase-II clinical trials for Glioma in France (Unknown route)